Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression - PubMed (original) (raw)
Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression
W S Griffin et al. Neurosci Lett. 1994.
Abstract
Activated microglia containing IL-1 alpha-immunoreactive (IL-1 alpha +) product were increased 3-fold in number in the acute phase following head injury, a risk factor for later development of Alzheimer's disease, and this increase was correlated with a 7-fold increase in the number of neurons with elevated beta-amyloid precursor protein (beta-APP) levels (R = 0.78; P < 0.05). Furthermore, clusters of beta-APP+ dystrophic neurites present in these patients were invariably associated with activated IL-1 alpha + microglia. These findings suggest that early overexpression of IL-1 alpha and beta-APP is a priming event for later neuropathological changes evident at end stages of Alzheimer's disease.
Figures
Fig. 1
A: numbers (mean ± S.E.M.) of IL-1_α_+ microglia and β_-APP+ neurons in mesial temporal lobe tissue sections from 7 head-injured and 6 control patients.*P < 0.05; **P < 0.01. B: correlation between numbers of activated IL-1_α+ microglia and _β_-APP+ neurons in 7 head-injured patients (R = 0.78; P < 0.05).
Fig. 2
β_-APP+ (red) neurites and IL-1_α+ (brown) microglia in dual-labeled immunohistochemically reacted tissue sections from mesial temporal lobe of control (A), head-injured (B), and Alzheimer's (C) patients. Bar = 15 _μ_m.
Similar articles
- Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
Sheng JG, Mrak RE, Griffin WS. Sheng JG, et al. Neuropathol Appl Neurobiol. 1995 Aug;21(4):290-301. doi: 10.1111/j.1365-2990.1995.tb01063.x. Neuropathol Appl Neurobiol. 1995. PMID: 7494597 - Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
Griffin WS, Sheng JG, Roberts GW, Mrak RE. Griffin WS, et al. J Neuropathol Exp Neurol. 1995 Mar;54(2):276-81. doi: 10.1097/00005072-199503000-00014. J Neuropathol Exp Neurol. 1995. PMID: 7876895 - Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
Mrak RE, Sheng JG, Griffin WS. Mrak RE, et al. J Neuropathol Exp Neurol. 1996 Mar;55(3):273-9. doi: 10.1097/00005072-199603000-00002. J Neuropathol Exp Neurol. 1996. PMID: 8786385 Free PMC article. - Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease.
Cummings BJ, Su JH, Geddes JW, Van Nostrand WE, Wagner SL, Cunningham DD, Cotman CW. Cummings BJ, et al. Neuroscience. 1992 Jun;48(4):763-77. doi: 10.1016/0306-4522(92)90265-4. Neuroscience. 1992. PMID: 1378573 - Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.
Sheng JG, Griffin WS, Royston MC, Mrak RE. Sheng JG, et al. Neuropathol Appl Neurobiol. 1998 Aug;24(4):278-83. doi: 10.1046/j.1365-2990.1998.00122.x. Neuropathol Appl Neurobiol. 1998. PMID: 9775393 Free PMC article.
Cited by
- The duality of the inflammatory response to traumatic brain injury.
Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. Lenzlinger PM, et al. Mol Neurobiol. 2001 Aug-Dec;24(1-3):169-81. doi: 10.1385/MN:24:1-3:169. Mol Neurobiol. 2001. PMID: 11831551 Review. - Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.
Griffin WS, Mrak RE. Griffin WS, et al. J Leukoc Biol. 2002 Aug;72(2):233-8. J Leukoc Biol. 2002. PMID: 12149413 Free PMC article. Review. - Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review.
Mrak RE, Griffin WS. Mrak RE, et al. EOS. 1996;16(3-4):80-84. EOS. 1996. PMID: 24478534 Free PMC article. - Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes.
Evans LP, Woll AW, Wu S, Todd BP, Hehr N, Hedberg-Buenz A, Anderson MG, Newell EA, Ferguson PJ, Mahajan VB, Harper MM, Bassuk AG. Evans LP, et al. J Neurotrauma. 2020 Jun 15;37(12):1463-1480. doi: 10.1089/neu.2019.6725. Epub 2020 Mar 16. J Neurotrauma. 2020. PMID: 32056479 Free PMC article. - Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia.
Lok HC, Katzeff JS, Hodges JR, Piguet O, Fu Y, Halliday GM, Kim WS. Lok HC, et al. Sci Rep. 2023 Jun 2;13(1):8942. doi: 10.1038/s41598-023-35945-4. Sci Rep. 2023. PMID: 37268663 Free PMC article.
References
- Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 1992;58:454–460. - PubMed
- Clinton J, Ambler MW, Roberts GW. Post traumatic Alzheimer's disease: Predominance of a single plaque type, Neuropathol. Appl. Neurobiol. 1991;17:69–74. - PubMed
- da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannotta FS, Vitkovic L. Gliosis in human brain: relationship to size but not other properties of astrocytes. Brain Res. 1993;600:161–165. - PubMed
- Dinarello CA, Wolff SM. The role of Interleukin-1 in disease. New Engl. J. Med. 1993;328:106–113. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical